World Jan 27, 2022
The news comes a day after rival vaccine developer Pfizer Inc. launched a similar trial.
The news comes a day after rival vaccine developer Pfizer Inc. launched a similar trial.
The decades of discoveries before the ‘miraculous’ sprint to a vaccine
The breakthroughs behind the vaccines unfolded over decades, little by little, as scientists across the world pursued research in disparate areas.
Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate
While there were some caveats, the findings will likely add to concerns around the efficacy of Sinovac’s and Sinopharm Group’s shots, which have been widely used in the developing world.
The ins and outs of Japan's COVID-19 booster shot rollout
Japan recommends people receive a different shot for their third doses to the one they received in the initial rollout, but what's the rationale behind that strategy?
Moderna says its booster dose appears protective against omicron
The data, which has not yet been peer reviewed, tested blood from people who had received the vaccine against a pseudovirus engineered to resemble the omicron variant.
The deal underscores efforts by governments around the world to build up local production and prepare for future pandemic threats.
What’s worst about omicron so far is the uncertainty
How should the world respond to omicron? We just have to wait as there is information that we don’t yet have. And for many, the waiting itself is the problem.
Moderna says new vaccine for omicron may be ready in early 2022
Moderna's chief medical officer says the company should know about the ability of the current vaccine to provide protection in the next couple of weeks.
Japan to make some exceptions to eight-month guideline for COVID-19 booster shots
Elderly people in care homes and patients at hospitals hit by cluster infections could receive booster shots six months after their second doses.
Did AstraZeneca keep Britain safer from COVID-19 than Europe?
It's suggested that Britain’s home-grown jab may be the reason the country is faring better with the latest COVID-19 wave than Europe. Still, is there evidence for that?
Takeda applies for approval of Moderna's booster shots in Japan
A government subcommittee of health experts will discuss the use of the vaccine as a booster shot in late December at the earliest.
Moderna cuts 2021 sales forecast for COVID-19 vaccine; shares tumble
Moderna said it was now expecting sales of between $15 billion and $18 billion from $20 billion estimated previously.